AVITA Medical, Inc. (RCEL) Discusses Business Progress, Operational Changes and Sequential Revenue Growth Transcript
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical to Host Investor Webinar Briefing
Avita Medical Q1 Earnings Call Highlights
AVITA Medical, Inc. (RCEL) Q1 2026 Earnings Call Transcript
AVITA Medical Reports First Quarter 2026 Financial Results
AVITA Medical Names Cary Vance as Chief Executive Officer
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
AVITA Medical to Announce First Quarter 2026 Financial Results
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc. - RCEL
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock?
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
AVITA Medical, Inc. Investigated by the Portnoy Law Firm
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of “Hold” from Analysts
Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know
AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress Transcript
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call Transcript
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
Avita Medical: Set Up For A Turnaround
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
AVITA Medical, Inc. (RCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
AVITA Medical Announces Changes to its Board of Directors
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
Here Are Thursday's Top Wall Street Analyst Research Calls: AON, Apollo Global Managment, Bullish, Jack Henry, Marsh & McClennan, Nasdaq, NVIDIA,
Avita Medical Inc. (NASDAQ:RCEL) Given Average Rating of “Reduce” by Brokerages
AVITA Medical, Inc. (RCEL) Discusses Advanced Wound Care Solutions and Data-Driven Approaches in Clinical Healing Transcript
AVITA Medical, Inc. (RCEL) Q3 2025 Earnings Call Transcript
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
New Strong Sell Stocks for Oct. 31st
AVITA Medical to Announce Third Quarter 2025 Financial Results
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation – RCEL
AVITA Medical Welcomes Support for RECELL® in Burns in Australia
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
AVITA Medical Announces CEO Transition
AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into AVITA Medical, Inc. and Encourages Investors to Contact the Firm